代谢综合征与颅内肿瘤切除术后医疗并发症增加相关
该研究基于ACS NSQIP 2012-2016数据,纳入15,136例幕上脑肿瘤开颅手术患者,按有无代谢综合征(MetS)分为两组(MetS+占4.1%,MetS-占95.9%)。结果显示MetS+组医疗并发症、非计划再入院、再手术和死亡率均显著高于MetS-组,但手术部位并发症无统计学差异。
要点
- MetS+组医疗并发症几乎翻倍(15.8% vs 8.5%,P≤0.001)。
- MetS+组再入院(14.6% vs 10.4%)、再手术(6.9% vs 4.6%)和死亡率(5.6% vs 2.9%)均更高。
- 手术部位并发症两组无统计学差异(7.4% vs 5.8%,P=0.098)。
核心结论
- MetS诊断似乎不增加手术部位事件发生率,但MetS+患者发生一般医疗并发症、再入院、再手术和死亡的可能性显著更高。
研究设计与样本
- 回顾性队列研究,数据来自美国外科医师学会国家手术质量改进计划(ACS NSQIP)2012-2016年,纳入15,136例幕上脑肿瘤开颅手术患者,按MetS存在(4.1%)或不存在(95.9%)分为两组。
主要发现
- MetS+组年龄显著更大(63.4 vs 56.1岁),且更可能合并多系统合并症(所有P≤0.05),但手术时间相似(P=0.573)。
- MetS+组医疗并发症数量几乎翻倍(15.8% vs 8.5%;P≤0.001)。
- MetS+组非计划再入院(14.6% vs 10.4%;P=0.004)、再手术(6.9% vs 4.6%;P=0.007)和死亡率(5.6% vs 2.9%;P≤0.001)均更频繁。
- 手术部位局部并发症无统计学显著增加(7.4% vs 5.8%;P=0.098)。
临床怎么用
- 神经外科医生应意识到MetS患者开颅肿瘤切除术后发生一般医疗并发症、再入院、再手术和死亡的可能性显著更高。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: When diagnosed simultaneously, obesity, diabetes, and hypertension form a medical constellation called metabolic syndrome (MetS). The prevalence of MetS in Western cultures has been on a steady increase and MetS has been associated with increased postoperative complications in multiple surgical settings. OBJECTIVE: In this study, we evaluate the relationship between MetS and the outcomes of craniotomy for supratentorial brain tumor. METHODS: Cases of craniotomy for supratentorial brain tumors were extracted from the American College of Surgeons National Surgical Quality Improvement Program for 2012-2016. The 15,136 patients identified were divided into 2 cohorts based on the presence (4.1%) or absence (95.9%) of MetS. We compared the 2 cohorts for preoperative comorbidities, intraoperative details, and postoperative morbidity and mortality. RESULTS: Patients in the MetS+ cohort were significantly older (63.4 vs. 56.1 years) and were more likely to show comorbidities of various organ systems (all P ≤ 0.05). However, operative times were similar (P = 0.573). The number of medical complications was almost double in patients with MetS (15.8% vs. 8.5%; P ≤ 0.001). Unplanned readmissions (14.6% vs. 10.4%; P = 0.004), reoperations (6.9% vs. 4.6%; P = 0.007), and mortality (5.6% vs. 2.9%; P ≤ 0.001) were also more frequent in our MetS+ group. Nevertheless, surgical complications localized to the operative site were not statistically increased (7.4% vs. 5.8%; P = 0.098). CONCLUSIONS: A diagnosis of MetS does not seem to be associated with increased rates of surgical site events. However, neurosurgeons should be aware that these patients have a significantly higher likelihood of general medical complications, readmissions, reoperations, and death.
引用
- Nia AM, Branch DW, Maynard K, et al. Metabolic Syndrome Associated with Increased Rates of Medical Complications After Intracranial Tumor Resection. World Neurosurg. 2019. PMID: 30878753. doi:10.1016/j.wneu.2019.03.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。